Wed March 30th, 2022
Sponsor: Rep. Angie Craig — D — MN
Limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023. The bill caps cost-sharing under the Medicare prescription drug benefit for insulin products at (1) $35 in 2023 regardl...
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.×